Share of Acinetobacter spp. resistant to carbapenems in Europe in 2021, by country

Percentage of invasive Acinetobacter species isolates resistant to carbapenem antibiotics in Europe in 2021, by country

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

October 2023

Region

Worldwide, Europe

Survey time period

2021

Supplementary notes

Acinetobacter species are bacteria causing healthcare-associated infections, such as pneumonia associated with the use of a ventilator, central line-associated bloodstream infections, and postoperative wound infections.
Carbapenem antibiotics include imipenem and meropenem.

Release date represents the date figures were accessed.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you Antibiotic use in the United Kingdom (UK)

Overview - UK

5

Consumption - England

6

England - opinions, attitudes, knowledge

4

Consumption - Scotland

5
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.